Prosecution Insights
Last updated: August 18, 2026

Examiner: ALLEY, GENEVIEVE S

Tech Center 1600 • Art Units: 1611 1614 1617 1619

This examiner grants 60% of resolved cases

Performance Statistics

60.3%
Allow Rate
At TC average
772
Total Applications
+48.4%
Interview Lift
1065
Avg Prosecution Days
Based on 735 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
14.1%
§102 Novelty
50.1%
§103 Obviousness
18.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19544782 FORMULATIONS COMPRISING A COMBINATION OF ACID-NEUTRALIZING POLYMERIC AND NON-POLYMERIC SUBSTANCES FOR ORAL ADMINISTRATION OF ACTIVE AGENTS Non-Final OA Entera Bio Ltd.
18284625 NON-ELUTABLE ANTIMICROBIAL GLASS COMPOSITION, AND METHOD FOR PREPARING ANTIMICROBIAL GLASS POWDER USING SAME Final Rejection LG ELECTRONICS INC.
17759568 METHODS OF CONTROLLING OR PREVENTING PANAMA DISEASE IN BANANA PLANTS Non-Final OA SYNGENTA CROP PROTECTION AG
18721056 COMPOSITION COMPRISING HYDROPHOBICIZED POLYION COMPLEX PARTICLE Non-Final OA L'Oreal
18711436 COSMETIC COMPOSITION FOR CARING FOR THE SKIN Final Rejection L'OREAL
18589817 SKIN PENETRATION IMPROVER Final Rejection KANEKA CORPORATION
18579422 METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL Final Rejection Omya International AG
18711261 METHODS FOR INTRATUMORAL DELIVERY OF CRISPR/CAS SYSTEMS Final Rejection Christiana Care Gene Editing Institute, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month